AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

AGM Information Apr 12, 2023

3714_rns_2023-04-12_433af336-5afe-43e6-8b15-e2be4b7c50e0.html

AGM Information

Open in Viewer

Opens in native device viewer

Photocure ASA - Notice of the Annual General Meeting 3 May 2023

Photocure ASA - Notice of the Annual General Meeting 3 May 2023

Oslo, Norway, 12 April 2023: Photocure ASA (OSE: PHO), calls for the annual

general meeting of Photocure ASA to be held on 3 May 2023 at 17:00 hours (CEST),

virtual through the general meeting portal administered by Euronext Securities

Oslo (the "Euronext Securities Portal").

The general meeting will be webcasted live and a link will be available on the

company's website in due time in advance of the general meeting. It will not be

possible to attend in person. Shareholders may also vote in advance or submit a

proxy with voting instructions.

The notice convening the general meeting, including the agenda and the board's

proposals to the matters to be dealt with, is enclosed with this notification

and will be sent to all shareholders with known addresses.

Relevant documents referred to in the notice are made available on

www.photocure.com.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

Email: [email protected]

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, which makes

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

Talk to a Data Expert

Have a question? We'll get back to you promptly.